Evidence map›Paper›PMID 39725777›Full record

ArticleInvestigational new drugs2025

Deficiency of myeloid discoidin domain receptor 2 aggravates melanoma lung and bone metastasis.

Yue Sun, Liangliang Wei, Hao Liu, Gaoyang Zong, Zhihao Xia, Xiangyang Li, Zhanhai Yin, Dageng Huang, Yan Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Investigational new drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yue Sun *Department of Orthopaedics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Liangliang Wei *Honghui Hospital, Xi'an Jiaotong University, Xi'an, People's Republic of China.
Hao LiuDepartment of Orthopaedics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Gaoyang ZongDepartment of Orthopaedics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Zhihao XiaHonghui Hospital, Xi'an Jiaotong University, Xi'an, People's Republic of China.
Xiangyang LiDepartment of Orthopaedics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Zhanhai YinDepartment of Orthopaedics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Dageng HuangHonghui Hospital, Xi'an Jiaotong University, Xi'an, People's Republic of China. huangdageng@xjtu.edu.cn.
Yan ZhangDepartment of Orthopaedics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China. zhangyan1114@xjtu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma, one of the most prevalent cancers worldwide, frequently metastasizes to the lung and bones. Tumor-associated macrophages play essential roles in melanoma metastasis but the underlying mechanism remains obscure. We previously demonstrated that specific knockout of Ddr2, a receptor tyrosine kinase, exacerbates systemic inflammation via modulating macrophage repolarization. To investigate whether myeloid Ddr2 regulates melanoma growth and metastasis, we injected B16BL6 melanoma cells into Ddr2

Indexed as

Bone NeoplasmsDiscoidin Domain Receptor 2Lung NeoplasmsMelanomaMelanoma, ExperimentalAnimalsCell Line, TumorCell MovementHumansMacrophagesMiceMice, Inbred C57BLMice, KnockoutDiscoidin Domain Receptor 2Bone metastasisDiscoidin domain receptor 2MelanomaTAM

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.